 7. Symptomatic or untreated leptomeningeal or brain metastases or spinal cord compression patients with controlled central nervous system CNS disease, i.e. asymptomatic and currently receiving concurrent intrathecal chemotherapy, are eligible upon discussion with the Principal InvestigatorI. 